Cell-based assay technologies offer tremendous
utility in the drug discovery process and are becoming increasingly
important in triaging compounds in the early development
stages assessed through toxicity and drugability. IBA’s
cell-based assay method development and compound analysis
services will remove the guess work from your drug discovery
efforts.
Here are some cell-based supported areas of service:
Median Inhibition Concentration Determination (IC50)